Intelligent Bio Solutions Inc. INBS recently announced that it has secured a key patent in the United States relating to the Intelligent Fingerprinting Drug Screening Cartridge. This is the company’s ...

Price Action: At the last check on Wednesday, INBS stock was down 0.57% at $1.75 during the premarket session.

All of the shares of common stock are being offered by Intelligent Bio Solutions Inc. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Intelligent Bio Solutions expects a sixth U.S. patent for its innovative non-invasive drug testing technology, enhancing market entry plans. Intelligent Bio Solutions Inc. (INBS), a medical ...

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid ...

ultimately boosting the performance of the INBS stock over time. Meanwhile, INBS currently has a market capitalization of $11.9 billion. The company expects an earnings growth of 80.4% in 2025.